110 related articles for article (PubMed ID: 8588208)
1. TAT and PAP in hemodialysis patients: two cats in a bag?
Haznedaroğlu IC; Erdem Y; Dündar S; Cağlar S; Kirazh S
Thromb Res; 1995 Dec; 80(5):447-9. PubMed ID: 8588208
[No Abstract] [Full Text] [Related]
2. Thrombin-antithrombin complex and alpha2-plasmin inhibitor-plasmin complex levels after cesarean section in normal pregnancies and pre-eclampsia.
Hayashi M; Hamada Y; Ohkura T
Int J Gynaecol Obstet; 2003 Aug; 82(2):213-6. PubMed ID: 12873784
[No Abstract] [Full Text] [Related]
3. [Increased complexes between protease and protease inhibitor in the plasma from patients with neoplasm].
Okadome T; Maruyama I; Shinmyouzu K; Jounosono M; Osame M
Rinsho Ketsueki; 1988 Dec; 29(12):2283-6. PubMed ID: 2977624
[No Abstract] [Full Text] [Related]
4. Experimental haemorrhage and blood component transfusion in humans: no change in plasma concentration of thrombin-antithrombin complex and plasmin-antiplasmin complex.
Henriksson AE; Nilsson TK; Jansson U; Bergqvist D
Thromb Res; 1996 Jun; 82(5):409-15. PubMed ID: 8771701
[TBL] [Abstract][Full Text] [Related]
5. Increased activated protein C: protein C inhibitor complex and decreased protein C inhibitor levels in patients with chronic renal failure on maintenance hemodialysis.
Takagi M; Wada H; Mukai K; Minamikawa K; Wakita Y; Deguchi K; Junji N; Hayashi T; Suzuki K; Shiku H
Clin Appl Thromb Hemost; 1999 Apr; 5(2):113-6. PubMed ID: 10725991
[TBL] [Abstract][Full Text] [Related]
6. Thrombin generation in patients with thrombotic thrombocytopenic purpura.
Takahashi H; Tatewaki W; Wada K; Shibata A
Am J Hematol; 1989 Dec; 32(4):255-7. PubMed ID: 2479264
[TBL] [Abstract][Full Text] [Related]
7. Hemostatic abnormalities in patients with thrombotic complications on maintenance hemodialysis.
Inoue A; Wada H; Takagi M; Yamamuro M; Mukai K; Nakasaki T; Shimura M; Hiyoyama K; Deguchi H; Gabazza EC; Mori Y; Nishikawa M; Deguchi K; Shiku H
Clin Appl Thromb Hemost; 2000 Apr; 6(2):100-3. PubMed ID: 10775031
[TBL] [Abstract][Full Text] [Related]
8. Haemostatic markers of procoagulant imbalance in Behçet's disease.
Haznedaroğlu IC; Ozcebe O; Celik I; Dündar SV; Kirazhi S
Eur J Haematol; 1996 Jul; 57(1):107-8. PubMed ID: 8698121
[No Abstract] [Full Text] [Related]
9. Coagulation, thrombophilia and patency of arteriovenous fistula in children undergoing haemodialysis compared with healthy volunteers: a prospective analysis.
Fadel FI; Elshamaa MF; Abdel-Rahman SM; Thabet EH; Kamel S; Kandil D; Ibrahim MH; El-Ahmady M
Blood Coagul Fibrinolysis; 2016 Mar; 27(2):190-8. PubMed ID: 26829282
[TBL] [Abstract][Full Text] [Related]
10. Significance of elevated thrombin-antithrombin III complex and plasmin-alpha 2-plasmin inhibitor complex in the acute stage of nontraumatic subarachnoid hemorrhage.
Itoyama Y; Fujioka S; Takaki S; Morioka M; Hide T; Ushio Y
Neurosurgery; 1994 Dec; 35(6):1055-60. PubMed ID: 7533897
[TBL] [Abstract][Full Text] [Related]
11. [Changes in coagulation and fibrinolysis cascades upon extracorporeal circulation].
Kanamori N; Koiwa F; Uda S
Nihon Rinsho; 1991 Dec; 49 Suppl():81-6. PubMed ID: 1839690
[No Abstract] [Full Text] [Related]
12. Coagulation and fibrinolysis activation markers in prostatic carcinoma patients.
Geenen RW; Delaere KP; van Wersch JW
Eur J Clin Chem Clin Biochem; 1997 Feb; 35(2):69-72. PubMed ID: 9056745
[TBL] [Abstract][Full Text] [Related]
13. Activation of blood coagulation and fibrinolysis in diabetes mellitus: evaluation by plasma levels of thrombin-antithrombin III complex and plasmin-alpha 2-plasmin inhibitor complex.
Takahashi H; Tsuda A; Tatewaki W; Wada K; Niwano H; Shibata A
Thromb Res; 1989 Sep; 55(6):727-35. PubMed ID: 2528845
[TBL] [Abstract][Full Text] [Related]
14. Changes in peritoneal coagulation and fibrinolysis after discontinuation of chronic peritoneal dialysis.
Homma S; Masunaga Y; Kurosu M; Inoue M; Sakurai T; Asano Y
Perit Dial Int; 2002; 22(2):178-83. PubMed ID: 11990401
[TBL] [Abstract][Full Text] [Related]
15. Imbalance of coagulation and fibrinolysis can predict vascular access failure in patients on hemodialysis after vascular access intervention.
Hasuike Y; Kakita N; Aichi M; Masachika S; Kantou M; Ikeda Takahashi S; Nanami M; Nagasawa Y; Kuragano T; Nakanishi T
J Vasc Surg; 2019 Jan; 69(1):174-180.e2. PubMed ID: 29914835
[TBL] [Abstract][Full Text] [Related]
16. [Studies on coagulation-fibrinolytic system in diabetic nephropathy--with reference to plasma TAT and alpha 2PIC].
Watanabe S; Ogihara T; Iyori S; Kaneshige H; Nomoto Y; Sakai H
Nihon Jinzo Gakkai Shi; 1990 Sep; 32(9):995-9. PubMed ID: 2148199
[TBL] [Abstract][Full Text] [Related]
17. High plasma level of plasmin-alpha 2-plasmin inhibitor complex is predictor of poor prognosis in patients with lung cancer.
Taguchi O; Gabazza EC; Yoshida M; Yamakami T; Kobayashi H; Shima T
Clin Chim Acta; 1996 Jan; 244(1):69-81. PubMed ID: 8919202
[TBL] [Abstract][Full Text] [Related]
18. [Plasma levels of antithrombin III, thrombin-antithrombin III complex, alpha 2 plasmin inhibitor and plasmin alpha 2 plasmin inhibitor complex in normal and sick newborn infants].
Shiiki M; Ariyoshi N; Nakamura T; Shirahata A
Rinsho Ketsueki; 1991 Jul; 32(7):758-65. PubMed ID: 1833569
[TBL] [Abstract][Full Text] [Related]
19. Correlation between clotting and collagen metabolism markers in rheumatoid arthritis.
Gabazza EC; Osamu T; Yamakami T; Ibata H; Sato T; Sato Y; Shima T
Thromb Haemost; 1994 Feb; 71(2):199-202. PubMed ID: 7514817
[TBL] [Abstract][Full Text] [Related]
20. Coagulation and fibrinolysis factors in dialysis patients with and without ischemic heart disease.
Oda H; Ohno M; Ohashi H
Adv Perit Dial; 2000; 16():152-5. PubMed ID: 11045282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]